327. 特発性血栓症(遺伝性血栓性素因によるものに限る。) Disease details / Clinical trials / Drug dev / DR info /


臨床試験数 : 3 / 薬物数 : 13 - (DrugBank : 3) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 1

薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Clexane
   Research, Development & Innovation Department, UHCW NHS Trust
      2015   Phase 3   EUCTR2015-002357-35-GB   Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Clexane/lovenox
   Academic Medical Center Amsterdam
      2018   Phase 3   EUCTR2012-001447-43-AT   Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Dalteparin sodium
   Research, Development & Innovation Department, UHCW NHS Trust
      2015   Phase 3   EUCTR2015-002357-35-GB   Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Enoxaparin
   Academic Medical Center Amsterdam
      2018   Phase 3   EUCTR2012-001447-43-AT   Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Enoxaparin sodium
   Research, Development & Innovation Department, UHCW NHS Trust
      2015   Phase 3   EUCTR2015-002357-35-GB   Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Fragmin
   Research, Development & Innovation Department, UHCW NHS Trust
      2015   Phase 3   EUCTR2015-002357-35-GB   Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Innohep
   Research, Development & Innovation Department, UHCW NHS Trust
      2015   Phase 3   EUCTR2015-002357-35-GB   Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Tinzaparin sodium
   Research, Development & Innovation Department, UHCW NHS Trust
      2015   Phase 3   EUCTR2015-002357-35-GB   Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States